Results 111 to 120 of about 20,263 (262)

Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial

Journal of Clinical Psychopharmacology, 2019
Background Neuropsychiatric safety and relative efficacy of varenicline, bupropion, and transdermal nicotine patch (NRT) in those with psychiatric disorders are of interest.
A. E. Evins, N. Benowitz, R. West, C. Russ, T. McRae, D. Lawrence, A. Krishen, L. St Aubin, M. Maravić, R. Anthenelli   +9 more
semanticscholar   +1 more source

The data set describing cognitive performance after varenicline administration in a 3-choice serial reaction time task in rats

Data in Brief, 2017
The data shows attentional function, impulsivity, motivation, motor function, and motor activity in rats treated with varenicline, a stop-smoking aid.
Yu Ohmura, Hitomi Sasamori, Iku Tsutsui-Kimura, Takeshi Izumi, Takayuki Yoshida, Mitsuhiro Yoshioka   +5 more
doaj   +1 more source

Safety of varenicline as an aid to smoking cessation in professional drivers and its impact on driving behaviors: An observational cohort study of taxi drivers in Beijing

Tobacco Induced Diseases, 2020
Introduction Varenicline is an effective smoking cessation medicine. However, the possible adverse neuropsychiatric events reported by Food and Drug Administration for varenicline may cause safety problems for professional drivers.
Shuilian Chu, Lirong Liang, Hang Jing, Di Zhang, Zhaohui Tong   +4 more
doaj   +1 more source

Helping Smokers Quit: State Cessation Coverage [PDF]

, 2008
Analyzes state health insurance coverage for treatments to quit smoking and how coverage through state Medicaid, state employee health plans, private insurance, and "quitlines" saves states healthcare costs.

core  

The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence [PDF]

BACKGROUND: Tobacco smoking is the cause of many preventable diseases and premature deaths in the UK and around the world. It poses enormous health- and non-health-related costs to the affected individuals, employers, and the society at large.
Brown, AK, Ekpu, VU
core   +1 more source

The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. [PDF]

, 2012
BACKGROUND: The txt2stop trial has shown that mobile-phone-based smoking cessation support doubles biochemically validated quitting at 6 months. This study examines the cost-effectiveness of smoking cessation support delivered by mobile phone text ...
Cairns, John, Free, Caroline, Guerriero, Carla, Roberts, Ian, Rodgers, Anthony, Whittaker, Robyn   +5 more
core   +2 more sources

The alcohol cue‐exposure paradigm as a screening tool for alcohol use disorder medication development: A critical review

Alcohol, Clinical and Experimental Research, Volume 49, Issue 11, Page 2412-2426, November 2025.
The alcohol cue‐exposure paradigm has a long history in alcohol use disorder (AUD) research. This review examined the paradigm's utility as a screening tool for AUD medication development and offers recommendations for its refinement. In summary, while the alcohol cue‐exposure paradigm has a strong foundation in AUD pharmacotherapy research, its future
Dylan E. Kirsch, Erica N. Grodin, Lorenzo Leggio, Sherry A. McKee, Lindsay R. Meredith, Ethan H. Mereish, Robert Miranda Jr, Steven J. Nieto, Stephanie S. O'Malley, Joseph P. Schacht, Lara A. Ray   +10 more
wiley   +1 more source

Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials

Comprehensive Psychiatry, 2019
Background: The effects of the combination therapy of varenicline and bupropion in smoking cessation are still controversial. Methods: Databases including PubMed, EMBASE, Cochrane Library and Web of Science were scanned without time and language ...
Zhaoshuang Zhong, Shijie Zhao, Yan Zhao, Shuyue Xia   +3 more
doaj   +1 more source

Nicotinic receptors [PDF]

, 2014
Regulation of normal or abnormal behaviour is critically controlled by the central serotonergic systems. Recent evidence has suggested that serotonin (5-HT) neurotransmission dysfunction contributes to a variety of pathological conditions, including ...
A Auclair, A Beyeler, A Coppen, A Dahlstrom, A Fletcher, A Fletcher, A Gobert, A Jain, A Markou, A Pazos, AC Farley, AJ Grottick, AJ Grottick, AM Batman, AS Brown, AV Prochazka, B Chang, B Lendvai, BB Brodie, BL Jacobs, BM Twarog, BR Cooper, C Cirillo, C Nocjar, C Reperant, CP Müller, D Herve, D Hoyer, D Hoyer, D Kooy van der, D Quarta, DE Nichols, DJ Balfour, DJ Hayes, DL Murphy, DL Willins, DM Tomkins, DV Herin, E Costa, E Esposito, E Quattrocki, EB Ribeiro, EC Azmitia, ED Levin, ED Levin, EJ Bockstaele Van, EJ Bockstaele Van, EJ Mills, F Jenck, G Chevalier, G Chiara Di, G Cucchiaro, G Cucchiaro, G Engberg, G Giovanni Di, G Giovanni Di, G Giovanni Di, G Giovanni Di, G Giovanni Di, G Giovanni Di, G Giovanni Di, G Giovanni Di, G Porras, G Porras, GA Higgins, GA Higgins, GA Higgins, GA Kennett, GA Kennett, GF Koob, GW Dalack, H Khalki, H Moukhles, H Rollema, H Rollema, H Rollema, H Takahashi, HD Mansvelder, J Arnt, J Dong, J Hannon, JA Ascher, JE Anderson, JE Slemmer, JF Cryan, JH Thompson, JK Abrams, JL Neisewander, JR Martin, JW Coe, K Guillem, K Touiki, KD Alex, KG Baker, KH Thomas, KJ Clemens, KL Summers, L Galindo-Charles, L Pozzi, LA Pockros, LL McMahon, M Bubser, M Costa, M Dols, M Giorgetti, M Pierucci, M Pompeiano, M Reuben, M Zaniewska, M Zaniewska, M Zaniewska, MD Doherty, ME Benwell, MF O'Neill, MJ Bubar, MJ Bubar, MJ Eisenberg, MJ Millan, MM Rapport, N Corvaja, N Maurice, NA Rigotti, NB Edwards, NG Schneider, NM Barnes, OT Phillipson, P Deurwaerdere De, P Deurwaerdere De, P Enkhbaatar, P Olausson, P Olausson, P Seth, PA Crooks, PBS Clarke, PH Hutson, PJ Fletcher, PJ Fletcher, PJ Fletcher, PJ Kenny, PJ Kenny, PM Whitaker-Azmita, RD Schwartz, RF Mucha, RM Bowker, RM Bowker, RS Bitner, RS Bitner, S Hjorth, S Mihailescu, S Navailles, S Prisco, SG Matta, SJ Bonasera, SM Hall, SM Hall, SP Ji, SP Ranade, TA Shahan, V Cornea-Hébert, V Erspamer, V Hillegaart, V Matteo Di, V Matteo Di, V Matteo Di, V Matteo Di, V Matteo Di, V Matteo Di, V Matteo Di, W Feldberg, WA Corrigall, X Li, Y Takada, Z Ma, ZJ Yu   +173 more
core   +1 more source

The Effect of Serotonin 5‐HT2C Receptor Modulation on Binge Drinking and Alcohol‐Seeking in Female Mice

Addiction Biology, Volume 30, Issue 11, November 2025.
Alcohol misuse remains a leading cause of preventable death worldwide, prompting research into novel pharmacotherapies for alcohol use disorder. Here we showed that lorcaserin, a potent serotonin 2C receptor (5‐HT2CR) agonist, effectively reduced alcohol consumption and seeking behaviours in mice. Despite concerns over potential off‐target effects with
Roberta G. Anversa, Linh Tran, Andrew A. Bolinger, Jia Zhou, Kathryn A. Cunningham, Andrew J. Lawrence, Erin J. Campbell   +6 more
wiley   +1 more source